Showing results (1621-1630 of 8,677) with videos related to

Sort By:
Pageof 868
Bioorganic Chemistry|January 15, 2024
Potential oral VEGFR2 inhibitors: Treatment of wet age-related macular degenerationXiaomeng Xiu, Mengzhen Li, Dexiang Hu, et al.
Bioorganic Chemistry|January 25, 2024
Study of novel ginsenoside metabolites targeting HSP70 as anti-prostate cancer drugsLei Xu, Shengnan Xiao, Zhi Chai, et al.
Bioorganic Chemistry|January 25, 2024
Multiple medicinal chemistry strategies of targeting KRAS: State-of-the art and future directionsYanguo Shang, Shengnan Fu, Qingjing Hao, et al.
Bioorganic Chemistry|January 26, 2024
Synthesis, antitumor activity evaluation of 2-selenocyano-3-selenocyanoalkyloxyestradiols with a bisselenocyanate structureYanmin Huang, Yang Cheng, Meizhen Wei, et al.
Bioorganic Chemistry|January 18, 2024
Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activitySamah Higazy, Nermin Samir, Ahmed El-Khouly, et al.
Bioorganic Chemistry|January 14, 2024
Design and synthesis of quinazolin-4-one derivatives as potential anticancer agents and investigation of their interaction with RecQ helicasesHanan S Haggag, Shaimaa M Aboukhatwa, Mohamed S Nafie, et al.
Bioorganic Chemistry|January 13, 2024
Decoding active compounds and molecular targets of herbal medicine by high-throughput metabolomics technology: A systematic reviewZhibo Wang, Sifan Guo, Ying Cai, et al.
Bioorganic Chemistry|January 11, 2024
Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitorsMohammed Salah Ayoup, Ahmed Ammar, Hamida Abdel-Hamid, et al.
Bioorganic Chemistry|January 9, 2024
Human serum albumin as a potential drug delivery system for N-methylated hot spot insulin analogs inhibiting hormone aggregationJoanna Wasko, Marian Wolszczak, Zuzanna Zajaczkowska, et al.
Bioorganic Chemistry|December 27, 2023
Iodoquinazoline-derived VEGFR-2 and EGFRT790M dual inhibitors: Design, synthesis, molecular docking and anticancer evaluationsAbeer A Mohamed, Sanadelaslam S A El-Hddad, Ahmed K B Aljohani, et al.
Pageof 868